JiangSu WuZhong Pharmaceutical Development Future Growth
Future criteria checks 4/6
JiangSu WuZhong Pharmaceutical Development is forecast to grow earnings and revenue by 78.9% and 17.9% per annum respectively. EPS is expected to grow by 78.8% per annum. Return on equity is forecast to be 12% in 3 years.
Key information
78.9%
Earnings growth rate
78.8%
EPS growth rate
| Pharmaceuticals earnings growth | 17.7% |
| Revenue growth rate | 17.9% |
| Future return on equity | 12.0% |
| Analyst coverage | Low |
| Last updated | 21 May 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3,930 | 368 | N/A | 358 | 2 |
| 12/31/2025 | 3,246 | 221 | N/A | 314 | 5 |
| 12/31/2024 | 2,815 | 137 | N/A | 122 | 5 |
| 3/31/2024 | 2,332 | -95 | -198 | -117 | N/A |
| 12/31/2023 | 2,240 | -72 | -286 | -204 | N/A |
| 9/30/2023 | 2,149 | -18 | -159 | -69 | N/A |
| 6/30/2023 | 2,341 | -29 | -43 | 44 | N/A |
| 3/31/2023 | 2,194 | -56 | -123 | -68 | N/A |
| 12/31/2022 | 2,026 | -76 | 15 | 56 | N/A |
| 9/30/2022 | 1,688 | -73 | -30 | -6 | N/A |
| 6/30/2022 | 1,527 | -66 | -183 | -157 | N/A |
| 3/31/2022 | 1,675 | -65 | -60 | -35 | N/A |
| 12/31/2021 | 1,775 | 23 | 423 | 448 | N/A |
| 9/30/2021 | 1,859 | -411 | -62 | -24 | N/A |
| 6/30/2021 | 1,787 | -418 | 111 | 150 | N/A |
| 3/31/2021 | 1,986 | -419 | 142 | 183 | N/A |
| 12/31/2020 | 1,872 | -506 | -459 | -415 | N/A |
| 9/30/2020 | 2,073 | -37 | -383 | -339 | N/A |
| 6/30/2020 | 2,243 | -7 | -258 | -196 | N/A |
| 3/31/2020 | 2,125 | 65 | -288 | -211 | N/A |
| 12/31/2019 | 2,110 | 65 | -264 | -166 | N/A |
| 9/30/2019 | 1,821 | -345 | -3 | 232 | N/A |
| 6/30/2019 | 1,701 | -317 | -187 | 49 | N/A |
| 3/31/2019 | 1,552 | -299 | -7 | 215 | N/A |
| 12/31/2018 | 1,702 | -286 | 96 | 334 | N/A |
| 9/30/2018 | 1,977 | 147 | 152 | 336 | N/A |
| 6/30/2018 | 2,131 | 152 | 241 | 433 | N/A |
| 3/31/2018 | 2,527 | 129 | 148 | 382 | N/A |
| 12/31/2017 | 2,960 | 133 | N/A | 249 | N/A |
| 9/30/2017 | 3,774 | 113 | N/A | 118 | N/A |
| 6/30/2017 | 4,490 | 134 | N/A | 259 | N/A |
| 3/31/2017 | 4,426 | 107 | N/A | 522 | N/A |
| 12/31/2016 | 3,989 | 72 | N/A | 693 | N/A |
| 9/30/2016 | 3,391 | 89 | N/A | 865 | N/A |
| 6/30/2016 | 2,865 | 36 | N/A | 667 | N/A |
| 3/31/2016 | 2,717 | 45 | N/A | 322 | N/A |
| 12/31/2015 | 2,928 | 49 | N/A | 41 | N/A |
| 9/30/2015 | 2,836 | 39 | N/A | -85 | N/A |
| 6/30/2015 | 2,914 | 41 | N/A | -277 | N/A |
| 3/31/2015 | 3,157 | 34 | N/A | -262 | N/A |
| 12/31/2014 | 3,066 | 41 | N/A | -318 | N/A |
| 9/30/2014 | 3,040 | 45 | N/A | -312 | N/A |
| 6/30/2014 | 3,683 | 50 | N/A | 27 | N/A |
| 3/31/2014 | 3,812 | 51 | N/A | 49 | N/A |
| 12/31/2013 | 3,875 | 51 | N/A | 230 | N/A |
| 9/30/2013 | 4,181 | 53 | N/A | 218 | N/A |
| 6/30/2013 | 3,614 | 52 | N/A | 224 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600200 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 600200 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 600200 is expected to become profitable in the next 3 years.
Revenue vs Market: 600200's revenue (17.9% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 600200's revenue (17.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600200's Return on Equity is forecast to be low in 3 years time (12%).